Comprehensive Clinical Guide: Endoscopic Hemostasis via Hemostatic Forceps (Coagrasper)

1. Introduction and Overview

Endoscopic hemostasis represents a cornerstone of modern therapeutic gastrointestinal (GI) endoscopy. Among the various thermal coagulation modalities, the Hemostatic Forceps (often referred to by the industry standard, "Coagrasper") has emerged as a gold-standard instrument for managing non-variceal upper and lower GI bleeding.

Unlike traditional heater probes or bipolar probes that rely on direct contact pressure and broad-surface coagulation, the Hemostatic Forceps functions by grasping the visible vessel or tissue and applying precise, high-frequency (HF) electrical current directly to the target site. This targeted approach allows for "grasp-and-coagulate" therapy, which minimizes collateral thermal damage to the surrounding mucosa and provides superior mechanical tamponade prior to the application of energy. This guide provides a clinical deep-dive into the application, technical mechanism, and procedural protocols associated with this life-saving intervention.

2. Technical Specifications and Mechanisms

The Coagrasper is a bipolar or monopolar electrosurgical device designed to be passed through the working channel of a standard endoscope.

Mechanical Design

• Rotatable Tip: Allows the operator to align the forceps jaws precisely with the vessel axis.
• Opening/Closing Mechanism: Controlled by a handle at the proximal end, enabling the physician to "tent" the tissue or vessel away from the muscularis propria to prevent perforation.
• Insulated Sheath: Protects the working channel of the endoscope from electrical arcing.

Mechanism of Action

The device operates on the principle of electrosurgical coagulation. By grasping the vessel, the forceps creates a localized circuit. The primary mechanisms include:
1. Mechanical Compression: The physical act of closing the forceps provides immediate tamponade of the bleeding vessel.
2. Thermal Coagulation: High-frequency current is passed through the tissue, causing denaturation of proteins and contraction of the vessel walls (collagen shrinkage).
3. Desiccation: The current removes intracellular water, leading to rapid thrombus formation and permanent vessel occlusion.

3. Clinical Indications and Usage

The Coagrasper is indicated for patients presenting with active bleeding or high-risk stigmata of recent hemorrhage (HSRH).

Primary Indications:

• Peptic Ulcer Disease (PUD): Specifically Forrest Ia (spurting), Ib (oozing), and IIa (visible vessel) ulcers.
• Post-Polypectomy Bleeding: Immediate management of hemorrhage occurring after snare resection.
• Dieulafoy’s Lesions: Precision coagulation of the exposed submucosal artery.
• Diverticular Bleeding: Used to target the specific vessel within the diverticulum.

Clinical Decision-Making Matrix

4. Procedural Protocol: Step-by-Step

Pre-Operative Preparation

1. Hemodynamic Stabilization: Ensure the patient is resuscitated with fluids/blood products before endoscopic intervention.
2. Coagulation Profile: Review INR, PTT, and platelet count. Correct coagulopathy if possible.
3. Sedation: Deep sedation or general anesthesia (for airway protection in high-risk patients) is recommended to ensure a stable visual field.
4. Equipment Check: Verify the electrosurgical unit (ESU) settings. Typically, "Soft Coagulation" (Effect 5, 60-80W) is preferred over "Forced Coagulation" to prevent tissue charring.

The Intervention

1. Visualization: Clear the field using high-volume irrigation to identify the exact bleeding point.
2. Engagement: Position the endoscope to allow the Coagrasper to approach the vessel perpendicularly.
3. Grasping: Open the forceps, place the jaws around the vessel, and close them firmly.
4. Tenting: Gently lift the tissue to ensure the vessel is isolated from the deeper muscularis layers.
5. Coagulation: Apply the HF current. Observe for blanching of the tissue.
6. Inspection: Release the forceps. If bleeding has ceased, the vessel should appear flattened and blanched. If bleeding persists, repeat the process.

5. Post-Operative Recovery and Monitoring

Post-procedure management is critical to preventing re-bleeding.

• Observation: Admit the patient to a monitored unit (ICU or Step-down) for 24–48 hours.
• Dietary Protocol: NPO status for 6–12 hours, followed by a clear liquid diet, advancing to a soft diet as tolerated.
• Pharmacotherapy:
  • PPI Therapy: High-dose IV Proton Pump Inhibitors (e.g., Pantoprazole bolus + infusion) for 72 hours to promote clot stability.
  • Anticoagulation: Hold antiplatelet/anticoagulant therapy for 3–7 days, depending on the indication for the anticoagulation and the risk of recurrent bleeding.
• Follow-up: Repeat endoscopy is generally not required unless there is clinical evidence of recurrent hemorrhage (melena, hematemesis, or drop in hemoglobin).

6. Risks, Side Effects, and Contraindications

While highly effective, the Coagrasper is an invasive thermal device.

Potential Complications

• Perforation: The most serious risk. Occurs if the current is applied to thin-walled areas (e.g., the duodenum or the right colon) without adequate "tenting."
• Thermal Injury: Excessive current can cause delayed necrosis, leading to late-onset perforation.
• Recurrent Bleeding: If the vessel is not fully occluded or if the clot is prematurely dislodged.

Contraindications

• Hemodynamic Instability: Patient must be stabilized before attempting intervention.
• Full-thickness Lesions: If there is suspicion of a pre-existing perforation, thermal energy is contraindicated.
• Anatomical Inaccessibility: If the lesion cannot be safely visualized or the endoscope cannot be maneuvered into a safe position.

7. Alternative Treatments

While the Coagrasper is highly effective, it is often used in conjunction with or as an alternative to:
1. Endoscopic Clips (Hemoclips): Excellent for mechanical closure. Often used if thermal therapy fails or if the vessel is too large.
2. Epinephrine Injection: Used to induce vasoconstriction, providing a temporary window to perform thermal coagulation.
3. Hemospray: A topical hemostatic powder used for diffuse bleeding where target-specific grasping is impossible.
4. Argon Plasma Coagulation (APC): Non-contact thermal therapy; better for diffuse oozing but less effective for spurting arterial bleeds.

8. Frequently Asked Questions (FAQ)

Q1: Is Coagrasper better than Hemoclips?
A: It depends on the lesion. Hemoclips are superior for mechanical closure of large vessels, while Coagrasper is superior for precision coagulation and "sealing" smaller vessels within complex tissue.

Q2: What is the ideal ESU setting?
A: Most experts recommend "Soft Coagulation" at 60–80 Watts. This promotes deep, slow coagulation without causing excessive surface charring.

Q3: Can I use Coagrasper on a patient with a pacemaker?
A: Yes, provided the ESU is set up correctly and the return electrode is placed away from the heart. Consult with a cardiologist if the patient has an ICD (Implantable Cardioverter Defibrillator).

Q4: How do I prevent perforation with the Coagrasper?
A: Always "tent" the tissue. Lifting the vessel away from the deeper muscularis layer ensures the thermal energy is confined to the mucosa and submucosa.

Q5: What if the forceps sticks to the tissue?
A: This usually happens due to excessive charring. Stop the current, wait a few seconds for the tissue to cool, and gently wiggle the forceps to detach. Do not pull with force.

Q6: Can this be used in the colon?
A: Yes, but with extreme caution. The colonic wall is significantly thinner than the stomach; use lower power and ensure minimal contact time.

Q7: How many times can one vessel be coagulated?
A: Ideally, one or two applications should suffice. If bleeding continues after three attempts, switch to an alternative modality like a Hemoclip.

Q8: Does the Coagrasper handle come in different sizes?
A: Yes, various lengths and handle designs exist to match the specific endoscope used (e.g., gastroscope vs. colonoscope).

Q9: What is the failure rate?
A: Clinical studies indicate a primary hemostasis rate of >90% for non-variceal upper GI bleeding when performed by an experienced endoscopist.

Q10: Do I need to remove the clot before using the Coagrasper?
A: Yes. If a large clot covers the bleeding site, use irrigation or a snare to remove it to expose the underlying vessel for effective coagulation.

9. Conclusion

The Hemostatic Forceps (Coagrasper) is an indispensable tool in the therapeutic endoscopist's armamentarium. By combining the benefits of mechanical tamponade with controlled electrosurgical coagulation, it offers a safe and effective means of managing high-risk GI bleeding. Success depends on proper patient selection, meticulous technique—specifically the "grasp-and-tent" maneuver—and a deep understanding of electrosurgical principles. As technology evolves, the Coagrasper remains a reliable, cost-effective, and highly versatile solution for maintaining endoscopic hemostasis.